Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Helena Trottestam, AnnaCarin Horne, Maurizio Aricò et al. · Blood · 2011 · 677 citations · Full text

Medicine, Hematology, Oncology +14

ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures

Vasken Dilsizian, Stephen L. Bacharach, Rob Beanlands et al. · Journal of Nuclear Cardiology · 2016 · 615 citations · Full text

Medicine, Nuclear Medicine, Radiology +16

Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

Eli L. Diamond, Vivek Subbiah, A. Craig Lockhart et al. · JAMA Oncology · 2017 · 405 citations · Full text

Medicine, Oncology, Pharmacology +13

Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With <i>BRAF^V600E</i>-Mutated Erdheim-Chester Disease

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Journal of Clinical Oncology · 2014 · 287 citations

Medicine, Oncology, Pharmacotherapy +13

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

Jean Donadieu, Islam Amine Larabi, M. Tardieu et al. · Journal of Clinical Oncology · 2019 · 220 citations · Full text

Medicine, Oncology, Pediatrics +13